Safe Orthopaedics (ALSAF) | Stock Overview & Key Data
Safe Orthopaedics S.A. | Mid-cap | Healthcare
Safe Orthopaedics S.A. | Mid-cap | Healthcare
Safe Orthopaedics Performance Comparison
Stock Range
Today's Range
Low: €2.40
High: €2.40
on September 17, 2025
52 Week Range
Low: €0.00
High: €2.40
on July 3, 2025
on September 17, 2025
All-Time High: €2.40 on July 4, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€218.9M
EPS
-18,676,728.00
P/E Ratio (TTM)
N/A
Forward P/E
-34.29
P/B Ratio
N/A
PEG Ratio
-34.29
Div. Yield
N/A
ROE
101.53%
Beta
0.314
Debt to Equity
-156.53
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-263.51%
Profit Margin
74.41%
Returns and Earnings
Return on Assets (TTM)
-8.19%
Return on Equity (TTM)
101.53%
EBITDA
€-5.3M
Net Income (TTM)
€-205.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€63.69
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Safe Orthopaedics ALSAF | 218.94M Mid-cap | 0.00% | 0.00% | 0.00% | 23,900.00% | 3,328.57% | 0.00% | 0.00% | 0.00% |
| EssilorLuxottica EL | 125.69B Large-cap | 2.96% | 2.50% | 13.71% | 4.17% | 17.21% | 34.96% | 97.98% | 153.35% |
| Sartorius Stedim DIM | 17.55B Large-cap | 9.19% | 4.11% | -6.22% | -8.24% | -0.16% | 7.76% | -41.17% | -36.58% |
| Amplitude Surgical AMPLI | 299.85M Mid-cap | 0.81% | 0.81% | 2.46% | 4.17% | 95.31% | 89.39% | 106.27% | 194.81% |
| Crossject S.A ALCJ | 81.86M Small-cap | 14.01% | 9.82% | -1.10% | -5.79% | -20.09% | -26.03% | -34.43% | -17.89% |
| Visiomed Group SA ALVMG | 66.34M Small-cap | -4.35% | 10.00% | 22.22% | 10.00% | 29.41% | 22.22% | -55.10% | -77.78% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1M
Average 90-Day Volume
418K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALSAF's 52-week high and low?
- In the last 52 weeks, Safe Orthopaedics reached a high of €2.40 (on September 17, 2025) and a low of €0.00 (on July 3, 2025).
- What is the market cap and P/E ratio for ALSAF?
- Curious about Safe Orthopaedics's size and valuation? Its market capitalization stands at 218.94M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -34.29.
- Does ALSAF pay dividends? If so, what's the yield?
- As for dividends, Safe Orthopaedics isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Safe Orthopaedics's main competitors or similar companies to consider before investing?
When looking at Safe Orthopaedics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL125.69B Healthcare Medical Instruments & Supplies 34.96% 97.98% Sartorius Stedim
DIM17.55B Healthcare Medical Instruments & Supplies 7.76% -41.17% Amplitude Surgical
AMPLI299.85M Healthcare Medical Instruments & Supplies 89.39% 106.27% Crossject S.A
ALCJ81.86M Healthcare Medical Instruments & Supplies -26.03% -34.43% Visiomed Group SA
ALVMG66.34M Healthcare Medical Instruments & Supplies 22.22% -55.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Safe Orthopaedics S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Safe Orthopaedics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 101.53%, the Debt to Equity ratio from the most recent quarter is -156.53, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSAF?
- Looking at Safe Orthopaedics's growth, its revenue over the trailing twelve months (TTM) was €6M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSAF stock is held by insiders and institutions?
- Wondering who owns Safe Orthopaedics stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.